Product
voretigene neparvovec-rzyl
1 clinical trial
1 indication
Clinical trial
A Post-Authorization, Multicenter, Longitudinal, Observational Safety Registry Study for Patients Treated With Voretigene Neparvovec in USStatus: Active (not recruiting), Estimated PCD: 2025-06-01